GlassScriptPhysician profile
James Robert Demarco
NPI 1174510622
$3,883.68
in general payments reported to CMS, 2019-2025
15 companies · $204 in 2025
The $204 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $617 · 2020: $97.06 · 2021: $11.31 · 2022: $158 · 2023: $2,558 · 2024: $238 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,715 · Food and Beverage: $1,286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,714.70 |
| Food and Beverage | $1,285.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $1,818.30 | 2019-2023 | |
| Peerless Surgical INC. | $1,034.46 | 2020-2024 | |
| Ferring Pharmaceuticals INC. | $320.30 | 2019-2025 | Euflexxa |
| Arthrex, INC. | $278.08 | 2023 | |
| Bioventus LLC | $75.83 | 2019-2025 | Durolane, Xcell |
| Si-Bone, INC. | $64.94 | 2022 | |
| Pacira Therapeutics, INC. | $60.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $55.68 | 2025 | Juggerknotless Soft Anchor |
| Smith+Nephew, INC. | $49.70 | 2022-2023 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Curonix LLC | $34.61 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Depuy Synthes Sales INC. | $21.28 | 2024 | Orthovisc, Monovisc |
| Convatec INC. | $18.65 | 2019 | |
| Glaxosmithkline, LLC. | $18.54 | 2025 | Shingrix |
| Stryker Corporation | $18.38 | 2024 | Aequalis Flex Revive, Aequalis Perform Reversed, Aequalis Ascend Flex |
| Pfizer INC. | $14.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Demarco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.